arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Inspire Medical Systems, Inc.

INSP

$69.04 ▼ -2.21 (-3.10%) at close

10 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

Inspire Medical Systems, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.0B

Dividend Yield —

Revenue Growth 13.6% ↘

Op. Margin 5.6% ↗

ROIC 14.4% ↗

FCF / Share $2.67 ↘

Trailing P/E 14.0x

Price / Book 2.5x

FCF Yield 3.9%

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$911.98M

↑ +13.6% —

Net Income Profit after all expenses

$145.42M

↑ +171.8% —

Operating Margin Operating profit as % of sales

5.6%

↑ +24.3% 44th

FCF / Share Free cash flow per share

$2.67

↓ -12.7% —

Long-Term Debt Long-term obligations

$24.50M

— 0.0% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Financial Health

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	13.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+70%)	28.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+256%)	53.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+565%)	74.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+834%)	102.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1179%)	40.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+408%)	62.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+677%)	77.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+864%)	—	—
EPS Growth YoY (%)	175.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	55.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	29.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	171.8% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	52.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-6.8% Weak ↑ Weak Improving Year-over-year change in net income	26.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-72.1% Weak ↓ Weak Declining Year-over-year change in net income	-52.3% Weak Weak Year-over-year change in net income	-24.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-12.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	8660.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-60.3% Weak Weak Year-over-year change in free cash flow	N/M	57.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	30.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	51.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	75.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	70.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	66.5% Excellent Excellent Compound annual revenue growth over 3 years	59.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	51.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	57.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	65.3% Excellent Excellent Compound annual revenue growth over 5 years	70.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	5.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-63%)	4.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-70%)	-6.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-143%)	-11.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-178%)	-17.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-214%)	-48.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-425%)	-42.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-384%)	-40.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-369%)	-56.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-473%)	—
Effective Tax Rate (%) (%)	-121.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	15.9% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+33%)	6.7% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-44%)	-3.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-128%)	-11.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-192%)	-18.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-250%)	-49.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-513%)	-40.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-438%)	-43.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-460%)	-61.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-611%)	—
FCF Margin (%) (%)	8.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	11.4% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	0.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	0.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-10.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-48.1% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-43.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-37.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-56.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.54x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	14.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	4.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-1206.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	5.6% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	4.5% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-6.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	18.6% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+24%)	7.8% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-48%)	-3.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-9.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-18.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-24.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-266%)	-23.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-13.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	—	—	—	0.11x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	—	0.18x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	—	—	—
Interest Coverage (x)	371.93x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	1640.14x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	—	-28.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-18.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-26.55x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.17x Weak Weak Operating income divided by interest expense Optimal: > 5x	-9.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-104.81M	$-150.15M	$-185.54M	$-441.59M	$-189.97M	$-190.52M	$1.64M	$-97.29M	—	—
Debt / EBITDA (x)	—	—	—	—	-0.63x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.71x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$31.05	$26.97	$21.32	$14.53	$8.56	$4.43	—	—	—	—
Basic EPS, GAAP (USD)	$4.95	$1.80	$-0.72	$-1.60	$-1.54	$-2.19	—	—	—	—
Free Cash Flow per Share (USD)	$2.67	$3.06	$0.03	$0.09	$-0.91	$-2.13	—	—	—	—
Book Value per Share (USD)	$27.33	$23.19	$19.37	$17.10	$8.35	$8.49	$5.80	$7.01	—	—
Tangible Book Value per Share (USD)	$27.33	$23.19	$19.37	$17.10	$8.35	$8.49	$5.80	$7.01	—	—
Basic Weighted Avg Shares (shares)	29.37M	29.76M	29.30M	28.07M	27.26M	26.07M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$487.60M	$542.30M	$515.63M	$468.85M	$227.23M	$249.14M	$153.78M	$188.12M	—	—
LT Debt (USD)	—	—	—	—	$24.50M	—	$24.50M	—	—	—
Total Equity (USD)	$781.16M	$689.70M	$572.51M	$496.01M	$229.05M	$229.75M	$139.84M	$164.00M	$1.33M	$-6.61M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$911.98M	$802.80M	$624.80M	$407.86M	$233.39M	$115.38M	$82.05M	$50.59M	$28.57M	—
Depreciation Expense (USD)	$13.96M	$6.55M	$2.85M	$1.86M	$1.22M	$840.00K	$495.00K	$393.00K	$285.00K	—
Net Income, GAAP (USD)	$145.42M	$53.51M	$-21.15M	$-44.88M	$-42.04M	$-57.20M	$-33.24M	$-21.83M	$-17.51M	—
Operating Cash Flow (USD)	$116.98M	$130.25M	$24.65M	$11.57M	$-20.12M	$-53.05M	$-32.85M	$-18.69M	$-15.79M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 40 quarters

Inspire Medical Systems, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INSP with peers